HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maxime Lugosi Selected Research

Maxime Lugosi Research Topics

Disease

3Critical Illness (Critically Ill)
08/2015 - 04/2011
2Infections
11/2016 - 04/2011
2Sepsis (Septicemia)
08/2011 - 04/2011
1Neoplasms (Cancer)
07/2023
1Autoimmune Diseases (Autoimmune Disease)
07/2023
1Thyrotoxicosis
01/2022
1Thyroiditis
01/2022
1Goiter
01/2022
1Sarcoidosis (Schaumann Disease)
01/2022
1Guillain-Barre Syndrome
07/2020
1Hepatitis E
07/2020
1Brachial Plexus Neuritis (Parsonage Turner Syndrome)
07/2020
1Cholestasis
07/2020
1Wounds and Injuries (Trauma)
07/2020
1Thrombosis (Thrombus)
11/2016
1Renal Insufficiency (Renal Failure)
08/2015
1Bacterial Infections (Bacterial Infection)
09/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2012
1Hypersensitivity (Allergy)
12/2012
1Pulmonary Embolism
12/2012
1Septic Shock (Toxic Shock Syndrome)
04/2011
1Fever (Fevers)
04/2011
1Endocarditis
04/2011
1Thrombophlebitis
04/2011

Drug/Important Bio-Agent (IBA)

1IpilimumabIBA
07/2023
1Immune Checkpoint InhibitorsIBA
07/2023
1Amiodarone (Amiodarona)FDA LinkGeneric
01/2022
1AntibodiesIBA
01/2022
1IodineIBA
01/2022
1Immunoglobulin M (IgM)IBA
07/2020
1Transaminases (Aminotransferases)IBA
07/2020
1RNA (Ribonucleic Acid)IBA
07/2020
1Dalteparin (Dalteparin Sodium)FDA Link
08/2015
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2015
1SteroidsIBA
09/2014
1Contrast MediaIBA
12/2012
1AnticoagulantsIBA
12/2012
1Local Anti-Infective Agents (Antiseptics)IBA
04/2011
1Anti-Bacterial Agents (Antibiotics)IBA
04/2011

Therapy/Procedure

3Catheters
11/2016 - 04/2011
3Central Venous Catheters
08/2015 - 04/2011
2Therapeutics
09/2014 - 04/2011
1Duration of Therapy
07/2023
1Length of Stay
12/2012